Microbiomics / Metagenomics
Microbiomics research is progressing at a rapid rate as we get a better understanding of the impact of the microbiome on our bodies.
Current and future advancements will have a profound socioeconomic impact globally. Eagle Genomics is actively engaged with global companies in their microbiomic R&D programmes. Our mixed expertise in biology, bioinformatics and knowledge management coupled with our powerful software platform has already transformed new product innovation in the microbiomic sector.
Market Impact of Microbiomics Analysis
We are helping to speed up and shape microbiomic research across a range of sectors and with the following benefits:
• Increase sales •
• Identify infection/contamination – avoid legal action •
• Find a new discovery •
• Increase R&D efficiency •
• Stay ahead of cycles/trends •
Eagle’s Microbiome Solution Architecture
Eagle Genomics leads the industry in configuring and deploying best-in-class microbiome workflow solutions. These run large-scale parallelized pipelines cost efficiently, with seamless connectivity between the source data and the scientists. The figure below shows Eagle’s high level architecture: